MYO News and Press, Myomo Inc. From 02/03/20

Approval To Be Determined on Case-by-Case Basis Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, tod...

Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced following approval of a reverse stock split range and authorized share reduction by stockholder...

To Provide Specialist Neurological Rehabilitation Services Myomo ® , Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and uppe...

Myomo, Inc. (MYO) Q3 2019 Earnings Conference Call November 12, 2019 04:30 PM ET Executives Adam Holdsworth - Investor Relations Paul Gudonis - Chairman and Chief Executive Officer Dave Henry - Chief Financial Officer Analysts Jim Sidoti - Sidoti and Company Ed Woo - Asce...

Myomo (NYSEMKT: MYO ): Q3 GAAP EPS of -$0.16 in-line. More news on: Myomo, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Growth Metrics Accelerating; Timing of Insurance Payments Affecting Short-term Revenue Growth Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...

Management to host Earnings Conference Call at 4:30 p.m. ET Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb pa...

Proceeds from Non-Dilutive Financing to be Used to Achieve Near-Term Milestones Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorde...

Microchip Technology CEO will continue as advisor to Myomo and as an investor Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders...

Goal of Business Development Program is to Expand Access of Company’s Product Line to Additional Country Markets Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for t...